T
EDIT icon

TCWP’s Editas Medicine EDIT Stock Holding History

TCWP’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-188
Closed -$3K – 692
2022
Q1 		$3K Buy
+188
New +$3.5K ﹤0.01% 1187

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

TCWP's EDIT Position: Q2 2022 in Review

TCWP sold out of Editas Medicine (EDIT) in Q2 2022, closing a stake of 188 shares — an estimated $3K sold.

TCWP first reported a position in EDIT in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 256 funds tracked by Wall St. Rank hold EDIT as of Q2 2022.

  • TCWP reported no remaining Editas Medicine position as of Q2 2022 after selling out during the quarter.
  • TCWP sold 188 Editas Medicine shares in Q2 2022, an estimated $3K.
  • TCWP first reported a position in Editas Medicine in Q1 2022 and held it in 1 quarter.
  • TCWP's Editas Medicine position peaked at $3K in Q1 2022.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.